Abstract

The single nucleotide polymorphism (SNP) rs835487 is associated with hip osteoarthritis (OA) at the genome-wide significance level and is located within CHST11, which codes for carbohydrate sulfotransferase 11. This enzyme post-translationally modifies proteoglycan prior to its deposition in the cartilage extracellular matrix. Using bioinformatics and experimental analyses, our aims were to characterise the rs835487 association signal and to identify the causal functional variant/s. Database searches revealed that rs835487 resides within a linkage disequilibrium (LD) block of only 2.7 kb and is in LD (r2 ≥ 0.8) with six other SNPs. These are all located within intron 2 of CHST11, in a region that has predicted enhancer activity and which shows a high degree of conservation in primates. Luciferase reporter assays revealed that of the seven SNPs, rs835487 and rs835488, which have a pairwise r2 of 0.962, are the top functional candidates; the haplotype composed of the OA-risk conferring G allele of rs835487 and the corresponding T allele of rs835488 (the G-T haplotype) demonstrated significantly different enhancer activity relative to the haplotype composed of the non-risk A allele of rs835487 and the corresponding C allele of rs835488 (the A-C haplotype) (p < 0.001). Electrophoretic mobility shift assays and supershifts identified several transcription factors that bind more strongly to the risk-conferring G and T alleles of the two SNPs, including SP1, SP3, YY1 and SUB1. CHST11 was found to be upregulated in OA versus non-OA cartilage (p < 0.001) and was expressed dynamically during chondrogenesis. Its expression in adult cartilage did not however correlate with rs835487 genotype. Our data demonstrate that the OA susceptibility is mediated by differential protein binding to the alleles of rs835487 and rs835488, which are located within an enhancer whose target may be CHST11 during chondrogenesis or an alternative gene.

Highlights

  • Osteoarthritis (OA) is a common disease of older individuals that is characterized by the focal loss of articular cartilage [1]

  • In order to determine the size of the OA susceptibility region marked by rs835487, we used LDlink [12], which utilises genotype data of 503 Europeans generated by the 1000 Genomes Project [13], to identify single nucleotide polymorphism (SNP) in high linkage disequilibrium (LD) with rs835487

  • This identified six additional SNPs in the European (EUR) population with an r2 ! 0.8 with rs835487; all seven SNPs are located within a 2726 bp region of intron 2 of CHST11, approximately 210 kb downstream of the transcription start site of the gene (Fig 1A and 1B)

Read more

Summary

Introduction

Osteoarthritis (OA) is a common disease of older individuals that is characterized by the focal loss of articular cartilage [1]. This loss usually occurs gradually over many years and typically results in chronic pain and severely impaired joint function by the sixth or seventh decade of life. A number of genome-wide and candidate-gene based studies have reported OA association signals that exceed or are close to the genome-wide significance threshold (reviewed in [5]). Many of these signals demonstrate association only in a particular joint type; for example, hips but not knees. Stratification by joint has proven essential in identifying OA association signals and highlights that, at the genetic level, OA aetiology is not uniform across the skeleton

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.